← Eichor
Study identifier: NCT06571149 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Condition: Ischemic Stroke  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhasePhase 4
Planned participants906
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

DO-IT is an international, multicenter, prospective, two-arm, randomized, open label, blinded endpoint superiority trial determining the safety and efficacy of intravenous thrombolysis (IVT) in participants experiencing an acute ischemic stroke (AIS) with recent (within the last 48 hours) intake of direct oral anticoagulant (DOAC). For this purpose, 906 adult participants experiencing an AIS with recent DOAC intake will be enrolled at several high-volume international stroke centers and randomly assigned in a ratio of 1:1 to one of two treatment arms: (1) IVT and standard of care/best medical treatment or (2) standard of care/best medical treatment. The DO-IT trial is a definitive test of the hypothesis that IVT is superior to standard of care for achieving better outcome at 90 days in AIS participants with recent DOAC intake.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Meinel, MD, PhD  ·  +41 31 66 4 25 67  ·  thomas.meinel@insel.ch

Freschta Zipser-Mohammadzada, PhD  ·  +41 31 63 2 60 83  ·  nctu@insel.ch

Always discuss trial participation with your own doctor first.

Locations (14)

UZ LeuvenLeuven, BelgiumNot Yet Recruiting
Hamilton Health SciencesHamilton, Ontario, CanadaNot Yet Recruiting
GHU Paris Psychiatrie et Neurosciences, Sainte AnneParis, FranceNot Yet Recruiting
Heidelberg University HospitalHeidelberg, GermanyNot Yet Recruiting
"Attikon" University HospitalAthens, GreeceNot Yet Recruiting
National Cerebral and Cardiovascular Center OsakaOsaka, Kansai, JapanNot Yet Recruiting
Academic Medical Center Amsterdam, Department of NeurologyAmsterdam, NetherlandsNot Yet Recruiting
Canterbury District Health BoardChristchurch, New ZealandNot Yet Recruiting
Akershus HospitalOslo, NorwayNot Yet Recruiting
Lisbon Central University Hospital CentreLisbon, PortugalNot Yet Recruiting
Vall d'Hebron Stroke CenterBarcelona, SpainNot Yet Recruiting
University Hospital BaselBasel, SwitzerlandNot Yet Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06571149